Perimeter Medical Imaging to Announce Topline Results from Pivotal Clinical Trial Evaluating B-Series OCT with ImgAssist AI in Breast-Conserving Surgeries on November 20th; Conference Call to Follow
Portfolio Pulse from
Perimeter Medical Imaging AI, Inc. is set to announce the topline results of its pivotal clinical trial for the B-Series OCT system with ImgAssist AI in breast-conserving surgeries on November 20, 2024. A conference call will follow the announcement.
November 18, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Perimeter Medical Imaging AI will announce pivotal trial results for its B-Series OCT system, potentially impacting its stock price.
The announcement of pivotal trial results is a significant event for Perimeter Medical Imaging AI, as it could influence investor perception and stock price. Positive results may lead to increased investor confidence and a potential stock price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100